Sharon Mates, Chairman, President & CEO: Intra-Cellular Therapies ITCI Sell · Filed 24/02/27

Trade details

Type: Insider sale
Amount: $873,710.82
Shares · price: 12,462 sh · $70.11 a share
Held after: 1,050,309 sh
Stock: Intra-Cellular Therapies ITCI
Person: Sharon MatesChairman, President & CEO
Trade date: 24/02/26
Filed: 24/02/27
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 24/01/27~24/03/27

Sharon Mates's recent trades

Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$4.2M
50,163 sh
$4.2M
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.4M
27,667 sh
$2.4M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2M
23,333 sh
$2M
Filed 24/12/06
Traded 24/12/04
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$129.9K
1,534 sh
$129.9K
Filed 24/12/06
Traded 24/12/05
Sharon MatesChairman and CEO
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$2.2M
29,832 sh
$2.2M
Filed 24/08/30
Traded 24/08/29

Sharon Mates, Chairman — sold $873.7K of Intra-Cellular Therapies ITCI · 1.2% of holdings · 10b5-1 plan | Whalegun